[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing
…, S Dirnhofer, JKC Chan, B Sander, G Ott, L Xerri… - Virchows Archiv, 2016 - Springer
Plasmacytic differentiation may occur in almost all small B cell lymphomas (SBLs), although
it varies from being uniformly present (as in lymphoplasmacytic lymphoma (LPL)) to very …
it varies from being uniformly present (as in lymphoplasmacytic lymphoma (LPL)) to very …
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3 …
…, F Offner, A López-Guillermo, D Belada, L Xerri… - The Lancet, 2011 - thelancet.com
Background Patients with follicular lymphoma can have long survival times, but disease
progression typically occurs 3–5 years after initial treatment. We assessed the potential …
progression typically occurs 3–5 years after initial treatment. We assessed the potential …
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
…, F Monville, J Dutcher, M Brown, P Viens, L Xerri… - Cancer research, 2009 - AACR
Tumors may be initiated and maintained by a cellular subcomponent that displays stem cell
properties. We have used the expression of aldehyde dehydrogenase as assessed by the …
properties. We have used the expression of aldehyde dehydrogenase as assessed by the …
The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular …
…, F Berger, C Gisselbrecht, L Xerri… - Blood, The Journal …, 2007 - ashpublications.org
The molecular alterations underlying the pathogenesis of angioimmunoblastic T-cell
lymphoma (AITL) and peripheral T-cell lymphoma, unspecified (PTCL-u) are largely …
lymphoma (AITL) and peripheral T-cell lymphoma, unspecified (PTCL-u) are largely …
Aldehyde dehydrogenase 1–Positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer
…, JM Extra, F Bertucci, J Jacquemier, L Xerri… - Clinical cancer …, 2010 - AACR
Purpose: To examine the role of cancer stem cells (CSC) in mediating metastasis in
inflammatory breast cancer (IBC) and the association of these cells with patient outcome in …
inflammatory breast cancer (IBC) and the association of these cells with patient outcome in …
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
…, JP Jais, M Parrens, A Martin, L Xerri… - Blood, The Journal …, 2012 - ashpublications.org
Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2)
occur in most grade 2 and 3 gliomas, secondary glioblastomas, and a subset of acute …
occur in most grade 2 and 3 gliomas, secondary glioblastomas, and a subset of acute …
Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia
L Quintanilla-Martinez, B Sander, JKC Chan, L Xerri… - Virchows Archiv, 2016 - Springer
Indolent lymphomas in the pediatric population were discussed during the 2014 European
Association for Haematopathology/Society of Hematopathology workshop in Istanbul …
Association for Haematopathology/Society of Hematopathology workshop in Istanbul …
Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
…, M Nezri, D Sainty, S Olschwang, L Xerri… - British journal of …, 2009 - Wiley Online Library
The myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal
haematological diseases characterized by ineffective haematopoiesis and predisposition to …
haematological diseases characterized by ineffective haematopoiesis and predisposition to …
Gene expression profiling of breast cell lines identifies potential new basal markers
…, P Finetti, J Adelaïde, N Cervera, S Fekairi, L Xerri… - Oncogene, 2006 - nature.com
A better molecular characterization of breast cell lines (BCL) may help discover new markers
to apply to tumour samples. We performed gene and protein expression profiling of 31 BCL …
to apply to tumour samples. We performed gene and protein expression profiling of 31 BCL …